UROKINASE THERAPY IN CLINICAL PULMONARY EMBOLISM - A NEW THROMBOLYTIC AGENT

被引:115
作者
SASAHARA, AA
CANNILLA, JE
BELKO, JS
MORSE, RL
CRISS, AJ
机构
关键词
D O I
10.1056/NEJM196711302772203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1168 / &
相关论文
共 15 条
[1]   THE RECALCIFICATION TIME OF BLOOD - ITS USE AS A MEASURE OF THE CLINICAL EFFECT OF HEPARIN [J].
BELKO, JS ;
WARREN, R .
ARCHIVES OF SURGERY, 1958, 76 (02) :210-218
[2]  
CAHILL JM, 1963, SURG GYNECOL OBSTET, V116, P486
[3]   FIBRINOLYTIC MECHANISMS AND DEVELOPMENT OF THROMBOLYTIC THERAPY [J].
FLETCHER, AP ;
SHERRY, S ;
ALKJAERSIG, N .
AMERICAN JOURNAL OF MEDICINE, 1962, 33 (05) :738-&
[4]  
FLETCHER AP, 1965, J LAB CLIN MED, V65, P713
[5]  
FRED HL, 1965, CLIN RES, V13, P25
[6]  
FREIMAN DG, 1965, PULMONARY EMBOLIC DI, P81
[7]   BLENDED SCINTISCANS OF LUNGS WITH A DUAL DETECTOR SYSTEM [J].
SASAHARA, AA ;
BELKO, JS ;
SIMPSON, RG .
RADIOLOGY, 1967, 88 (02) :363-&
[8]   CLINICAL AND PHYSIOLOGIC STUDIES IN PULMONARY THROMBOEMBOLISM [J].
SASAHARA, AA ;
CANNILLA, JE ;
MORSE, RL ;
SIDD, JJ ;
TREMBLAY, GM .
AMERICAN JOURNAL OF CARDIOLOGY, 1967, 20 (01) :10-&
[9]  
SASAHARA AA, 1965, PULMONARY EMBOLIC ED, P265
[10]  
SASAHARA AA, 1965, PULMONARY EMBOLIC ED, P81